重视和推进对遗传代谢性肝病的认识和研究

doi:10.3969/j.issn.1672-5069.2021.02.001

Abstract

Bai Jie, Zheng Sujun. Focus on the study of patients with inherited metabolic liver disease[J]. Journal of Practical Hepatology, 2021, 24(2): 153-155.

[1] Ferreira CR, Cassiman D, Blau N. Clinical and biochemical footprints of inherited metabolic diseases. II. Metabolic liver diseases. Mol Genet Metab, 2019, 127(2):117-121.
[2] 朱世殊,董漪,徐志强,等.2001-2010年儿童非病毒性肝病谱分析.传染病信息,2011,24(5):279-280.
[3] Wagner KH, Shiels RG, Lang CA, et al. Diagnostic criteria and contributors to Gilbert's syndrome. Crit Rev Clin Lab Sci, 2018, 55(2):129-139.
[4] Joshi D, Gupta N, Samyn M, et al. The management of childhood liver diseases in adulthood. J Hepatol, 2017, 66(3):631-644.
[5] Stättermayer AF, Halilbasic E, Wrba F, et al. Variants in ABCB4 (MDR3) across the spectrum of cholestatic liver diseases in adults. J Hepatol, 2020, 73(3):651-663.
[6] Roy A, Finegold MJ. Biopsy diagnosis of inherited liver disease. Surg Pathol Clin, 2010, 3(3):743-768.
[7] Kanungo S, Wells K, Tribett T, et al. Glycogen metabolism and glycogen storage disorders. Ann Transl Med, 2018, 6(24):474.
[8] 张杰,郑素军.溶血性黄疸的临床特征及鉴别诊断.临床肝胆病杂志,2020,36(6):423-1427.
[9] 白洁,郑素军,段钟平. 4种常见先天性高胆红素血症的临床特征及诊断思路. 临床肝胆病杂志,2019,35(8):1680-1683.
[10] Bull LN, Thompson RJ. Progressive familial intrahepatic cholestasis. Clin Liver Dis, 2018, 22(4):657-669.
[11] Feldman AG, Sokol RJ. Neonatal cholestasis: emerging molecular diagnostics and potential novel therapeutics. Nat Rev Gastroenterol Hepatol, 2019, 16(6):346-360.
[12] Sun A. Lysosomal storage disease overview. Ann Transl Med, 2018, 6(24):476.
[13] Nascimbeni F, Dionisi Vici C, et al. AISF update on the diagnosis and management of adult-onset lysosomal storage diseases with hepatic involvement. Dig Liver Dis, 2020, 52(4):359-367.
[14] Demirbas D, Coelho AI, Rubio-Gozalbo ME, et al. Hereditary galactosemia. Metabolism, 2018, 83:188-196.
[15] Demirbas D, Brucker WJ, Berry GT. Inborn errors of metabolism with hepatopathy: Metabolism defects of galactose, fructose, and tyrosine. Pediatr Clin North Am, 2018, 65(2):337-352.
[16] Członkowska A, Litwin T, Dusek P, et al. Wilson disease. Nat Rev Dis Primers, 2018, 4(1):21.
[17] Korman JD, Volenberg I, Balko J, et al. Screening for Wilson disease in acute liver failure: a comparison of currently available diagnostic tests. Hepatology, 2008, 48(4):1167-1174.
[18] 梁晨,段钟平,郑素军.测序技术的选用与检测报告解读.实用肝脏病杂志,2020, 23(3):307-311.

Focus on the study of patients with inherited metabolic liver disease

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Jia Qunling, Xu Zhibin, Han Shu. Implication of magnetic resonanceimaging-proton density fat fraction in patients with nonalcoholic fatty liver diseases [J]. Journal of Practical Hepatology, 2021, 24(3): 359-362.
[2]	Nan Dong, Hong Jinling, Jiang Haiyu. Efficacyof DCE-MRI in evaluating severity of gastroesophageal varices in patients with hepatitis B cirrhosis [J]. Journal of Practical Hepatology, 2021, 24(3): 407-410.
[3]	Wang Yaozheng, Wang Yulin, Lin Yi. Diagnostic efficacy of ¹⁸F-FDG PET/CT scan in patients with ntrahepatic cholangiocarcinoma [J]. Journal of Practical Hepatology, 2021, 24(3): 427-430.
[4]	Gan Yanying, Zhong Kai, Guan Yanling, et al. Diagnostic efficacy of ultrasonography,CT and MRCP in the diagnosis of extrahepatic bile duct stones [J]. Journal of Practical Hepatology, 2021, 24(3): 439-442.
[5]	Zhu Lin, Qin Gang. Progress in diagnosis and treatment of patients with pregnancy-specific liver disease [J]. Journal of Practical Hepatology, 2021, 24(3): 449-452.
[6]	Deng Yuting , Wei Minhua, Zhou Junying. What we should know about Gilbert syndrome [J]. Journal of Practical Hepatology, 2021, 24(2): 156-159.
[7]	Bai Jie, Ren Yan, Liang Chen, et al. Partial epidemiological analysis of patients with inherited metabolic liver disease admitted in Beijing You'an Hospital between 1996 and 2020 [J]. Journal of Practical Hepatology, 2021, 24(2): 164-167.
[8]	Qi Duan, Tang Huizhuo, Yang Jing, et. Shear wave velocity by acoustic radiation force impulse in patients with hepatolenticular degeneration [J]. Journal of Practical Hepatology, 2021, 24(2): 168-171.
[9]	Zhang Siwei, Kong Yin, Liu Tianfu, et al. Predictive value of histological activity index and fibrosis by liver stiffness measurement and ICGR15 in patients with hepatitis B and normal or minimally elevated serum ALT levels [J]. Journal of Practical Hepatology, 2021, 24(2): 184-187.
[10]	Dai Haifeng, Wang Tian, Lei Xun, et al. Diagnosticefficacy of transient elastography in combination with APRI and AAR in evaluating significant liver fibrosis in patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2021, 24(2): 196-199.
[11]	Yang Zhenhui, Gu Baohuan, Dai Xiaoling. Early screening of nonalcoholic steatohepatitis by FibroScan with liver controlled attenuation parameters [J]. Journal of Practical Hepatology, 2021, 24(2): 212-215.
[12]	Xu Chunling, Miao Chongchang, Liu Yucheng, et al. Clinicalimplications of MRI multi-echo dixon technique in diagnosing hepatic steatosis in patients with metabolic associated fatty liver disease [J]. Journal of Practical Hepatology, 2021, 24(2): 220-223.
[13]	Chen Shaohua, Wu Zhe, Wei Zhihong, et al. Serum oncogene and tumor suppressor gene levels in patients with hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2021, 24(2): 244-247.
[14]	Wang Ruoyu, Wu Yunan, Tang Dan. Diagnostic value of plasma Ki67 and miRNA-26b levels in patients with hepatocellular carcinoma [J]. Journal of Practical Hepatology, 2021, 24(2): 264-267.
[15]	Dai Xiaobing, Liu Qiyu, Wu Junhui. Diagnosis of focal lesions of liver by diffusion-weighted magnetic resonance imaging [J]. Journal of Practical Hepatology, 2021, 24(2): 268-271.